In December 2013, a federal judge decided it was the end of the road for plaintiffs who filed a class-action lawsuit against Cogent Solutions Group in December 2012 for allegedly claiming that its supplement – Baxyl Hyaluronan – provides joint health and mobility without any support for such claims. The judge, who, in technical terms, granted the company’s motion for judgment on the pleadings, determined that the plaintiffs failed to allege several things in their complaint, including:
- the nature of the misrepresentations made by the company;
- how the named plaintiff relied on those misrepresentations;
- the way the product did not perform as advertised;
- that the named plaintiff ingested the product; and
- that the named plaintiff was injured in some way by relying on the company’s misrepresentations.
For more details regarding the judge’s decision, click here to read the official decision.
(Hoffman et al v. Cogent Solutions Group, LLC, Case No. 13-cv-00079, D. NJ.).
Inquiry finds price comparison uses wireless carrier’s lowest tier plan but not one of its competitors.
Smartwatches, Smart Rings Marketed to Measure Blood Sugar
FDA warns consumers that devices cannot be trusted to give accurate blood sugar measurements.
Sidebar: Love is a lie
Courthouse News Service
What consumers should know about this purported homeopathic product.